(Q37774822)

23 August 2017

1 reference

title

Use of granulocyte colony-stimulating factor in patients with severe sepsis or septic shock (English)

1 reference

23 August 2017

0 references

1 reference

Rima A Mohammad

1

1 reference

23 August 2017

publication date

1 August 2010

1 reference

American Journal of Health-System Pharmacy

23 August 2017

published in

1 reference

23 August 2017

volume

67

1 reference

23 August 2017

issue

15

1 reference

23 August 2017

page(s)

1238-1245

1 reference

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

An audit of the use of granulocyte colony-stimulating factor in septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Physiology of granulocyte and macrophage colony-stimulating factors in host defense.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

31 March 2020

A question of balance

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Effect of preoperative prophylaxis with filgrastim in cancer neck dissection

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Structural Characterization of Natural and Recombinant Human Granulocyte Colony-Stimulating Factors1

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Treatment of intra-abdominal infection with granulocyte colony-stimulating factor

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Recombinant human granulocyte colony-stimulating factor and Pseudomonas burn wound sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Effects of granulocyte colony stimulating factor and monobactam antibiotics (Aztreonam) on neutrophil functions in sepsis.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Difference in the responses after administration of granulocyte colony-stimulating factor in septic patients with relative neutropenia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

APACHE II: a severity of disease classification system

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Multiple-organ failure. Generalized autodestructive inflammation?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Filgrastim in patients with pneumonia and severe sepsis or septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Early enteral nutrition in acutely ill patients: a systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Early goal-directed therapy in the treatment of severe sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Source control in the management of sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Impairment in gas exchange after granulocyte colony stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Common features in the onset of ARDS after administration of granulocyte colony-stimulating factor

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

Alveolar granulocyte colony-stimulating factor and alpha-chemokines in relation to serum levels, pulmonary neutrophilia, and severity of lung injury in ARDS.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090325

31 March 2020

Identifiers

DOI

10.2146/AJHP090325

1 reference

23 August 2017

1 reference